Lgnd stock split

TPL - Texas Pacific Land Trust Stock quote - CNNMoney.com Find real-time TPL - Texas Pacific Land Trust stock quotes, company profile, news and forecasts from CNN Business. Find real-time TPL - Texas Pacific Land Trust stock quotes, company profile, news Stock Splits - The Online Investor

LGND | Complete Ligand Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Ligand Pharmaceuticals - LGND - Stock Price & News | The ... Real time Ligand Pharmaceuticals (LGND) stock price quote, stock graph, news & analysis. Real time Ligand Pharmaceuticals (LGND) stock price quote, stock graph, news & analysis. Ligand Pharmaceuticals Incorporated (LGND) Stock Analysis ... Get breaking news and analysis on Ligand Pharmaceuticals Incorporated (LGND) stock, price quote and chart, trading and investing tools. Ligand Pharmaceuticals Incorpor (LGND) Stock Price, Quote ...

Jul 31, 2019 · 5 Top Losers In Healthcare Sector (RMTI, LGND, MIST) Contributor. -- A 1-for-10 reverse stock split of the Company's common stock was implemented on July 25, 2019. -- …

Find the latest on option chains for Ligand Pharmaceuticals Incorporated Common Stock (LGND) at Nasdaq.com. Ligand Pharma News, Ligand Pharma Quote, LGND Quote ... Jan 16, 2019 01:17 PM Ligand Pharma (LGND) call put ratio 1 call to 6 puts with focus on January 110 and 115 puts Jan 16, 2019 01:08 PM Ligand Pharma (LGND) slammed 20% on new Citron short LGND News Today (Ligand Pharmaceuticals) | MarketBeat

Kulicke & Soffa shares surge after investor urges buyback," by Gary Strauss, USA Today, April 22, 2014 Ligand Pharmaceuticals (NASDAQ: LGND) footwear company, at an average (adjusted for a 3:1 stock split) cost of $132, calling it 

Stock Splits - The Online Investor Apr 01, 2020 · All of the latest stock splits, posted as they are announced, from The Online Investor. Stock | AMEDICA Stock Price Today | Markets Insider

SAN DIEGO-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its previously disclosed 1-for-6 reverse stock split has become effective, …

LGND | Ligand Pharmaceuticals Inc. Analyst Estimates ... Nov 08, 2019 · Ligand Pharmaceuticals Inc. analyst estimates by MarketWatch. View LGND revenue estimates and earnings estimates, as well as analyst recommendations. Ligand Pharmaceuticals (LGND) Approves 1-for-6 Reverse ... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced Tuesday that its Board of Directors has approved a 1-for-6 reverse stock split to be effective by the end of November. At the effective Understand the What and Why of Stock Splits Jul 05, 2019 · For example, in a 2-for-1 stock split, an additional share is given for each share held by a shareholder.So, if a company had 10 million shares outstanding before the split, it will have 20

Stock split history for Aptevo Therapeutics since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.

See Ligand Pharmaceuticals Incorporated (LGND) history of stock splits. Includes date and ratio.

Alliant Energy (LNT) has 2 splits in our LNT split history database. The first split for LNT took place on September 26, 1988. This was a 2 for 1 split, meaning for each share of LNT owned pre-split, the shareholder now owned 2 shares. LGND: Ligand Pharmaceuticals, Inc. Yearly Stock Returns A year by year calculation of the yearly returns of Ligand Pharmaceuticals, Inc. using the actual trading prices LGND stock was at during each respective year. All stock splits for LGND have also been listed. Aptevo Therapeutics - Stock Split History | APVO | MacroTrends Stock split history for Aptevo Therapeutics since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. LGND 13F Hedge Fund and Asset Management Owners Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that focuses on drug discovery and early-stage development of pharmaceuticals that address critical unmet medical needs or that are more effective and/or safer than existing therapies.